CG-BM1 allogeneic human bone marrow mesenchymal stem cells

CG-BM1异体人骨髓间充质干细胞

Report date: 2026/05/26 20:00:28

Base Information

Drug NameCG-BM1 allogeneic human bone marrow mesenchymal stem cells
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsSarcopeniaStrokeRespiratory Distress Syndrome, Adult +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Saijun Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Saijun Biotechnology Co LtdSun Yat-Sen University
Inactive CompaniesN/A
Active IndicationsSarcopeniaStrokeRespiratory Distress Syndrome, Adult +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A